CrushSCI.com
91.4平均天数
79中位天数
41最短天数
238最长天数
1252025发文量

Paper Review Records

全部论文审稿周期

23 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

76 天

Histone lactylation-induced USP33 upregulation promotes TRAF2 stabilization and scleral remodeling in form-deprivation myopia

作者
Meng Guan; Jianhua Li; Yuanyuan Wang; Jianmei Cha; Boyong Zhang展开收起
作者单位
1. Department of Ophthalmology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China展开收起
PDF源文件 DOI 网页
101 天

EZH2 mediated epigenetic modifications induce HK2 expression through miR-152 downregulation in lung cancer progression

作者
Wen-Jing Liu; Jian-Ge Qiu; Rui-ke Zhang; Feng-Mei Zhou; Yan-Qiu Zhao; Lin Wang; Bing-Hua Jiang展开收起
作者单位
1. Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; 2. State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China展开收起
PDF源文件 DOI 网页
79 天

Hyperinsulinaemia and cholesterol gallstone disease: mechanisms linking metabolic dysfunction to Lithogenesis

作者
Huan Zhou; Sangui Wang; Yunfeng Cai; Qihua Duan; Qiuyan Zhang; Di Wang; Wanyong Yang展开收起
作者单位
1. Clinical Laboratory Center, Dongguan Institute of Gallbladder Disease Research, Dongguan Nancheng Hospital, Dongguan, People’s Republic of China; 2. Department of Hepatobiliary Surgery, Dongguan Institute of Gallbladder Disease Research, Dongguan Nancheng Hospital, Dongguan, People’s Republic of China; 3. School of Life and Health Technology, Dongguan University of Technology, Dongguan, People’s Republic of China展开收起
PDF源文件 DOI 网页
238 天

Actinidia chinensis polysaccharide suppresses imatinib resistance and malignant progression in gastrointestinal stromal tumors via the NPM1/PI3K/AKT pathway

作者
Junhua Yu; Jun Qian; Jianping Fan; Dejun Jiang; Hang Lu; Lulu Cao展开收起
作者单位
1. Department of Gastrointestinal Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, China; 2. Department of Pathology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, China展开收起
PDF源文件 DOI 网页
143 天

HNRNPAB drives glioblastoma proliferation by stabilizing EZH2 mRNA

作者
Qing Wang; Honglei Cheng; Xinyi Feng; Fufu Ji; Tao Liu; Qing Lan展开收起
作者单位
1. Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China; 2. State Key Laboratory of Metabolic Dysregulation & the Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China; 3. School of Clinical Medicine, UNSW Medicine & Health, The University of New South Wales, Sydney, Australia展开收起
PDF源文件 DOI 网页
54 天

P300-mediated H3K27 acetylation activates the TRAF3IP3/ERK axis to promote glioblastoma progression

作者
Qi Lin; Peng Yu; ZhengYu Zhang; XianZhen Chen; Jia Yin展开收起
作者单位
1. Department of Neurosurgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China展开收起
PDF源文件 DOI 网页

FAQ

Biology Direct审稿要多久?

截至2026-11-18,CrushSCI 收录了 Biology Direct 的 23 篇完整审稿记录。最快一篇从收稿到录用用了 41 天(Silymarin attenuates diabetic nephropathy in rats via modulation of the miRNA-223/NLRP3/caspase-1/GSDMD axis and inflammasome-related pyroptotic signaling,2026-04-23 收稿,2026-06-03 录用),最慢一篇用了 238 天;平均 91.4 天,中位数 79 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。